Skip to main content

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for sample collection kits for SARS-CoV-2 testing from Color Health and the Yale School of Public Health.

The Color COVID-19 Self-Swab Collection Kit with Saline is designed for the self-collection of anterior nasal swab specimens by adults either at home or in a healthcare setting. Collected samples, which may include viral RNA, are maintained in saline for transport to a Color-designated lab for molecular testing, according to the FDA.

Last month, Burlingame, California-based Color received EUA from the FDA for a direct-to-consumer versions of Color Health's loop-mediated isothermal amplification-based SARS-CoV-2 test and a companion nasal swab sample self-collection kit. 

Yale's SalivaDirect At-Home Collection Kit is designed for the unsupervised self-collection of saliva samples from adults at home. Samples are transported at ambient temperature for molecular diagnostic testing at a Yale School of Public Health-designed lab, the FDA said.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.